Compare OPAD & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPAD | CTSO |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | 140 | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.3M | 39.5M |
| IPO Year | N/A | 2008 |
| Metric | OPAD | CTSO |
|---|---|---|
| Price | $0.64 | $0.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $1.83 | ★ $5.38 |
| AVG Volume (30 Days) | ★ 632.3K | 61.5K |
| Earning Date | 04-30-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.79 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $22,503,908.00 |
| Revenue This Year | N/A | $10.34 |
| Revenue Next Year | $32.08 | $22.41 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 48.53 |
| 52 Week Low | $0.57 | $0.50 |
| 52 Week High | $6.35 | $1.39 |
| Indicator | OPAD | CTSO |
|---|---|---|
| Relative Strength Index (RSI) | 37.33 | 33.21 |
| Support Level | $0.57 | $0.50 |
| Resistance Level | $0.90 | $0.74 |
| Average True Range (ATR) | 0.06 | 0.04 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 12.88 | 4.99 |
Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services, including mortgage, listing, renovation, and buyer representation services.
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.